Trial Profile
Efficacy and safety of sofosbuvir-based regimens in patients with Hepatitis-C infection in routine clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ledipasvir; Ledipasvir/sofosbuvir; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2017 New trial record